
About Synnove Pharmaceuticals Private Limited
Data last updated:
Synnove Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC291869. Its GSTIN is 27AAYCS2467A2Z0 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Lakhiani Naraindas and Karishma Sunil Lakhiani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹26.76 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹85,060 (net margin 3.2%) and EBITDA of ₹1.98 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 21% over five years.
As per MCA filings, the company has open charges of ₹4.8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synnovepharma.com.
Company details
Contact details
Synnove Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is synnovepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No 05 Ground Floor Sahakarwadi Sahakar Sra Chs Ltd Off Mulund Goregaon Link Roa, D East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synnove Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synnove Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Synnove Pharmaceuticals Private Limited, buy the company report.
Financials of Synnove Pharmaceuticals Private Limited
FY 2025 filings availableSynnove Pharmaceuticals Private Limited reported revenue of ₹26.76 Lakh (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 4% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹85,060 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synnove Pharmaceuticals Private Limited, buy the company report.
Board of directors of Synnove Pharmaceuticals Private Limited
Synnove Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Lakhiani Naraindas | Director | 01 Mar 2017 | 9 Years 8 Months | Current |
| Karishma Sunil Lakhiani | Director | 01 Mar 2017 | 9 Years 8 Months | Current |
Auditor
Synnove Pharmaceuticals Private Limited is audited by RUPANI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RUPANI & ASSOCIATES | FY 2023 | 162157 |
Shareholding
The shareholding of Synnove Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Synnove Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2018 | 100199285 | Others | ₹4.8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Synnove Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synnove Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synnove Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAYCS2467A2Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Synnove Pharmaceuticals Private Limited, buy the company report.
Recent activity
Synnove Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Karishma Sunil Lakhiani was appointed as Director on 01 Mar 2017.
Frequently asked questions
Synnove Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 March 2017 (9+ years old) and is registered under CIN U74999MH2017PTC291869.
Synnove Pharmaceuticals has 2 current directors:
- Sunil Lakhiani Naraindas - Director
- Karishma Sunil Lakhiani - Director
The latest financial statements of Synnove Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Synnove Pharmaceuticals is 27AAYCS2467A2Z0, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Synnove Pharmaceuticals is U74999MH2017PTC291869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synnove Pharmaceuticals was incorporated on 01 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Karishma Sunil Lakhiani was appointed as Director on 01 Mar 2017. Sunil Lakhiani Naraindas was appointed as Director on 01 Mar 2017.
Synnove Pharmaceuticals can be reached through the website synnovepharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Synnove Pharmaceuticals is at Shop No 05 Ground Floor Sahakarwadi Sahakar Sra Chs Ltd Off Mulund Goregaon Link Roa, D East, Mumbai, Maharashtra, India – 400063.
Synnove Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

